Skip to content

Study · Not a test of the peptide alone · 2026

2 results

Micro/nanoparticle hybrid hydrogel platform with mild photothermal stimulation on abaloparatide in situ release for cranial bone regeneration.

Wu Y, Lu W, Salas-Hernandez JL, Wang R, Zhao Z, Zheng W, Li Y, Liao J

Journal of materials chemistry. B7 Oct 2026

PMID42758143 (opens in a new tab)DOI10.1039/d6tb00934d (opens in a new tab)PepBankPUB-42758143
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Abaloparatide (Tymlos) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Abaloparatide (Tymlos).

  1. 01AnimalNot a test of Abaloparatide (Tymlos) aloneAnimal study (in vivo)Efficacy outcome

    In a cranial bone defect model, abaloparatide hydrogel with mild photothermal stimulation promoted bone regeneration.

    In plain wordsIn animals, abaloparatide hydrogel with mild heat stimulation promoted bone regeneration.

    Peptide
    Abaloparatide (Tymlos)
    Outcome
    IncreaseBone regeneration
    Study

    n: not reported in source

    Cranial bone defect model
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    In the cranial bone defect model, the synergistic effect of ABL and mild PTT promoted neovascularization and bone regeneration, ultimately achieving significant bone repair.
    1 context sentence
    Summary · context
    As a result, abaloparatide (ABL)-encapsulated poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared. The nanoparticles were then incorporated into hydrogels for local delivery. GO-BPEI endowed the hydrogel with mild photothermal responsiveness and heat-triggered drug-release capability.

    In this study, Abaloparatide (Tymlos) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Abaloparatide (Tymlos).

  2. 02AnimalNot a test of Abaloparatide (Tymlos) aloneAnimal study (in vivo)Efficacy outcome

    In a cranial bone defect model, abaloparatide hydrogel with mild photothermal stimulation promoted neovascularization.

    In plain wordsIn animals, abaloparatide hydrogel with mild heat stimulation promoted new blood vessel formation.

    Peptide
    Abaloparatide (Tymlos)
    Outcome
    IncreaseNeovascularization
    Study

    n: not reported in source

    Cranial bone defect model
    Outcome group
    Wound healing · Cardiovascular

    Source sentences

    Summary
    In the cranial bone defect model, the synergistic effect of ABL and mild PTT promoted neovascularization and bone regeneration, ultimately achieving significant bone repair.
    1 context sentence
    Summary · context
    As a result, abaloparatide (ABL)-encapsulated poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared. The nanoparticles were then incorporated into hydrogels for local delivery. GO-BPEI endowed the hydrogel with mild photothermal responsiveness and heat-triggered drug-release capability.

    In this study, Abaloparatide (Tymlos) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Abaloparatide (Tymlos).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.